Cadila Healthcare has slipped almost 7% to Rs 888 after reporting 200 basis points drop in operating profit margins (OPM) to 26% for the first quarter ended June 30.
Meanwhile, the company has posted 15% year-on-year rise in its consolidated net profit at Rs 230 crore for Q1FY12. The company had recorded a net profit of Rs 199 crore in a year ago period. Without considering the dossier income, the growth in net profit was 19%, the pharmaceutical firm said in a filing to the stock exchanges.
Net sales grew 11% to Rs 1,174 crore from Rs 1,055 crore during the recently concluded quarter.
The stock opened at Rs 866, have seen a combined around 109,182 shares changing hands on the counter till 0949 hours.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app